Aethlon Medical (AEMD) Shares Outstanding (Weighted Average) (2010 - 2025)

Aethlon Medical (AEMD) has 16 years of Shares Outstanding (Weighted Average) data on file, last reported at $478310.0 in Q4 2025.

• For the quarter ending Q4 2025, Shares Outstanding (Weighted Average) rose 224.23% year-over-year to $478310.0; the trailing twelve-month figure through Dec 2025 stood at $478310.0 (up 224.23% YoY), and the FY2025 full-year result was $1.6 million, up 396.93% from the prior year.
• Shares Outstanding (Weighted Average) for Q4 2025 stood at $478310.0, up from $304960.0 in the prior quarter.
• Across five years, Shares Outstanding (Weighted Average) topped out at $15.5 million in Q2 2022 and bottomed at $4090.0 in Q1 2023.
• The 5-year median for Shares Outstanding (Weighted Average) is $2.1 million (2022), against an average of $4.5 million.
• The widest annual swing landed in 2024, when Shares Outstanding (Weighted Average) soared 7579.63%; it then tumbled 97.72% in 2025.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $15.4 million in 2021, then slumped by 85.1% to $2.3 million in 2022, then climbed by 9.67% to $2.5 million in 2023, then plunged by 94.14% to $147520.0 in 2024, then jumped by 224.23% to $478310.0 in 2025.
• The last three Shares Outstanding (Weighted Average) figures came in at $478310.0 (Q4 2025), $304960.0 (Q3 2025), and $2.1 million (Q2 2025), per Business Quant data.

Peer Comparison